ABEONA THERAPEUTICS INC.
ABEOUS売上高
$6M
百万USD
営業利益
$-89M
百万USD
純利益
$71M
百万USD
ROE
44.7%
最新FY
EPS
$1.01
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-16M | - |
| FY2021 | Q2 | - | $-15M | - |
| FY2021 | Q3 | $7M | $-7M | - |
| FY2021 | FY | $3M | $-85M | - |
| FY2022 | Q1 | $0M | $-21M | - |
| FY2022 | Q2 | $1M | $-8M | - |
| FY2022 | Q3 | - | $-9M | - |
| FY2022 | FY | $1M | $-40M | - |
| FY2023 | Q1 | $0M | $-9M | - |
| FY2023 | Q2 | $4M | $-17M | $0.92 |
| FY2023 | Q3 | - | $-12M | $-0.48 |
| FY2023 | FY | $4M | $-54M | $-2.53 |
| FY2024 | Q1 | - | $-32M | $-1.16 |
| FY2024 | Q2 | $4M | $7M | $-0.26 |
| FY2024 | Q3 | - | $-30M | $-0.63 |
| FY2024 | FY | $4M | $-64M | $-1.55 |
| FY2025 | Q1 | - | $-12M | $-0.24 |
| FY2025 | Q2 | $0M | $109M | $1.71 |
| FY2025 | Q3 | - | $-5M | $-0.10 |
| FY2025 | FY | $6M | $71M | $1.01 |
| FY2026 | Q1 | $9M | $-17M | $-0.30 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $3M | $10M | $3M | $1M | $4M | $4M | $6M |
| 営業利益 | $-24M | $-28M | $-58M | $-77M | $-81M | $-90M | $-51M | $-47M | $-64M | $-89M |
| 純利益 | $-22M | $-27M | $-57M | $-76M | $-84M | $-85M | $-40M | $-54M | $-64M | $71M |
| 総資産 | $111M | $179M | $174M | $223M | $151M | $80M | $64M | $64M | $109M | $220M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $99M | $170M | $134M | $178M | $103M | $51M | $27M | $15M | $44M | $159M |
| 営業CF | - | $-23M | $-39M | $-63M | $-35M | $-66M | $-43M | $-37M | $-56M | $-76M |
| EPS | - | - | - | - | - | - | - | $-2.53 | $-1.55 | $1.01 |
| BPS | $2.46 | $3.60 | $2.80 | $2.13 | $1.04 | $0.35 | $1.51 | $0.54 | $0.91 | $2.79 |
| ROE | -22.1% | -16.1% | -42.3% | -42.8% | -82.1% | -165.3% | -148.3% | -365.5% | -144.7% | 44.7% |